Military Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Press Releases.

Press releases published on October 24, 2026

Oct. 24, 2026

XBiotech annonce la nomination de Sushma Shivaswamy et Jan-Paul Simard aux postes de co-directeurs généraux

Indeterminate GlobeNewswire

Oct. 24, 2026

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma

Indeterminate GlobeNewswire

Oct. 24, 2026

NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…

Indeterminate GlobeNewswire

Oct. 24, 2026

KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination

Indeterminate GlobeNewswire

Oct. 24, 2026

KFSH erweitert den Zugang zur Notfallversorgung durch virtuelle Versorgung und die Koordination durch Fachärzte

Indeterminate GlobeNewswire

Oct. 24, 2026

KFSH élargit l’accès aux urgences grâce aux soins virtuels et à la coordination des spécialistes

Indeterminate GlobeNewswire

Oct. 24, 2026

AirTripMaker Launches Comprehensive Business Class Flight Routes Guide from the USA to 15 Major International Destinations and Regions

Indeterminate GlobeNewswire

Oct. 24, 2026

Alkanes borrningar bekräftar och utvidgar guld-antimon-mineralsystemet vid Nagambie i Victoria

Indeterminate GlobeNewswire

Oct. 24, 2026

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Indeterminate GlobeNewswire

Oct. 24, 2026

Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 24, 2026

INTELLIGENCE, ENLIGHTENED: LUXEED Makes Its Global Debut, Redefining Luxury and Driving Pleasure Through Intelligence

Indeterminate GlobeNewswire

Oct. 24, 2026

Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence

Indeterminate GlobeNewswire

Oct. 24, 2026

Darolutamidi yhdessä ADT- ja sädehoidon kanssa vähensi 58 prosentilla syövän leviämisen tai kuoleman vaaraa potilailla, joilla on suuri eturauhassyövän uusiutumisen riski

Indeterminate GlobeNewswire

Oct. 24, 2026

Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting

Indeterminate GlobeNewswire

Oct. 24, 2026

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 24, 2026

Yangguang News Launches Global Youth Short Video Campaign “Me, Tang Poetry, and AI”

Indeterminate GlobeNewswire

Oct. 24, 2026

World Famous Liquor Brands Sustainability Index Report (2026) Released

Indeterminate GlobeNewswire

Oct. 24, 2026

Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma

Indeterminate GlobeNewswire

Oct. 24, 2026

See It, Try It, Compare It: SIVP Brings CHERY’s “Technology. For Family” to Life

Indeterminate GlobeNewswire

Oct. 24, 2026

Global Media Test Drive the SOUEAST S08 DM: Real Roads, Real Experience

Indeterminate GlobeNewswire